Magenta therapeutics to participate in panel discussion at the 42nd annual cowen healthcare conference

Cambridge, mass.--(business wire)--magenta therapeutics (nasdaq: mgta), a clinical-stage biotechnology company developing novel medicines designed to bring the curative power of stem cell transplants to more patients, today announced that the company will participate in a cell therapy panel discussion at the 42nd annual cowen healthcare conference, to be held virtually, on wednesday, march 9th, 2022 at 9:10 a.m. et. a live webcast of the panel can be accessed on the magenta therapeutics website
DNTH Ratings Summary
DNTH Quant Ranking